Matt Cokely, global technical consultant director at Ecolab explores how rapid recovery in a GMP environment means restoring control through predefined, risk-based and inspection-defensible strategies that protect sterility assurance under pressure.
Vetter, a Contract Development and Manufacturing Organisation (CDMO), is celebrating the start of construction on its new site in Saarlouis with a traditional groundbreaking ceremony.
Emerson has announced major advancements to the AspenTech Inmation OT Data Fabric, establishing it as the foundational enterprise-scale intelligence layer for the AspenTech Inmation Data Platform.
Hongene Biotech Corporation has announced its support of SiranBio’s SA1211 program, showing how Hongene works across different stages of developing and manufacturing structurally complex oligonucleotide therapeutics.
Falc Borchard, VP of sales & application at PIA Automation North America discusses how with increasing regulatory expectations and uncertain global supply chains, pharmaceutical manufacturers are rethinking how they design and scale their operations.
As the global pharmaceutical industry advances into a phase defined by innovation, automation, and deeper collaboration, CPHI & PMEC India 2026 has announced an expansion.
Exciva, a biopharmaceutical company developing novel therapeutic compounds for the treatment of neuropsychiatric conditions, has announced the appointment of Mark Altmeyer as chairman of its board of directors.
Emmet Tilley, quality director at scientific and regulatory consultancy Broughton Group, outlines how creating a quality culture through established practices with new perspectives enables growth while maintaining regulatory integrity.
Informa Markets has announced its keynote speaker line-up for CPHI Americas 2026 (2-4th June), bringing together more than 80 industry thought leaders to address the most pressing challenges shaping the pharmaceutical industry.
Emerson has introduced the AspenTech AVA AI platform, specifically designed for industrial companies to accelerate AI adoption across the enterprise for measurable business impact.
